Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole.
Cockayne
S E
SE
Glet
R J
RJ
Gawkrodger
D J
DJ
McDonagh
A J
AJ
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D000369:Aged, 80 and over; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D003875:Drug Eruptions; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D004941:Esophagitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects* / Q000031:analogs & derivatives*; D054328:Proton Pump Inhibitors; D013276:Stomach Ulcer / Q000188:drug therapy
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole